These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 18633975)

  • 21. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.
    Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H
    J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of unusual very-long-chain fatty acid and ether lipid derivatives in the fibroblasts and plasma of patients with peroxisomal diseases using liquid chromatography-mass spectrometry.
    Takashima S; Toyoshi K; Itoh T; Kajiwara N; Honda A; Ohba A; Takemoto S; Yoshida S; Shimozawa N
    Mol Genet Metab; 2017 Mar; 120(3):255-268. PubMed ID: 28089346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional characterisation of peroxisomal β-oxidation disorders in fibroblasts using lipidomics.
    Herzog K; Pras-Raves ML; Ferdinandusse S; Vervaart MAT; Luyf ACM; van Kampen AHC; Wanders RJA; Waterham HR; Vaz FM
    J Inherit Metab Dis; 2018 May; 41(3):479-487. PubMed ID: 28849344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Photosensitized killing of cultured fibroblasts from patients with peroxisomal disorders due to pyrene fatty acid-mediated ultraviolet damage.
    Hoefler G; Paschke E; Hoefler S; Moser AB; Moser HW
    J Clin Invest; 1991 Dec; 88(6):1873-9. PubMed ID: 1752949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Our experience in the diagnosis of peroxisomal diseases with an abnormal fatty acid profile].
    López-Pisón J; Pérez-Delgado R; García-Oguiza A; Lafuente-Hidalgo M; García-Jiménez M; Calvo-Ruata ML; Peña-Segura JL; Rebage V; Girós-Blasco M; Coll MJ; Baldellou-Vázquez A
    Rev Neurol; 2008 Jul 1-15; 47(1):1-5. PubMed ID: 18592472
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of the pathway of alpha-oxidation of cerebronic acid in peroxisomes.
    Sandhir R; Khan M; Singh I
    Lipids; 2000 Oct; 35(10):1127-33. PubMed ID: 11104019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genotype-phenotype correlations in disorders of peroxisome biogenesis.
    Moser HW
    Mol Genet Metab; 1999 Oct; 68(2):316-27. PubMed ID: 10527683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Very-Long-Chain Fatty Acids Quantification by Gas-Chromatography Mass Spectrometry.
    Scott AI
    Methods Mol Biol; 2022; 2546():501-508. PubMed ID: 36127617
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial risk for bipolar disorder is not associated with impaired peroxisomal function: Dissociation from docosahexaenoic acid deficits.
    McNamara RK; Moser AB; Jones RI; Jandacek R; Patino LR; Strawn JR; Strakowski SM; DelBello MP
    Psychiatry Res; 2016 Dec; 246():803-807. PubMed ID: 27825781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simple analysis of plasmalogens in erythrocytes using gas chromatography/mass spectrometry with selected-ion monitoring acquisition.
    Caruso U
    Rapid Commun Mass Spectrom; 1996; 10(10):1283-5. PubMed ID: 8759335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisomal disorders: Improved laboratory diagnosis, new defects and the complicated route to treatment.
    Wanders RJA
    Mol Cell Probes; 2018 Aug; 40():60-69. PubMed ID: 29438773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measurement of peroxisomal fatty acid beta-oxidation in cultured human skin fibroblasts.
    Wanders RJ; Denis S; Ruiter JP; Schutgens RB; van Roermund CW; Jacobs BS
    J Inherit Metab Dis; 1995; 18 Suppl 1():113-24. PubMed ID: 9053546
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of pipecolic acid following trimethylsilyl and trifluoroacyl derivatisation on plasma filter paper by stable isotope GC-MS for peroxisomal disorders.
    Yoon HR; An YW
    Arch Pharm Res; 2010 Feb; 33(2):317-23. PubMed ID: 20195834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma and red blood cell fatty acids in peroxisomal disorders.
    Moser AB; Jones DS; Raymond GV; Moser HW
    Neurochem Res; 1999 Feb; 24(2):187-97. PubMed ID: 9972864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peroxisomal hereditary diseases].
    Chandoga J; Tomková M; Hlavatá A
    Bratisl Lek Listy; 1997 Jan; 98(1):32-42. PubMed ID: 9264803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peroxisomal disorders: the single peroxisomal enzyme deficiencies.
    Wanders RJ; Waterham HR
    Biochim Biophys Acta; 2006 Dec; 1763(12):1707-20. PubMed ID: 17055078
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of Very-Long-Chain and Branched-Chain Fatty Acids in Plasma by Liquid Chromatography-Tandem Mass Spectrometry.
    De Biase I; Pasquali M
    Methods Mol Biol; 2022; 2546():509-521. PubMed ID: 36127618
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multivariate analysis and model building for classifying patients in the peroxisomal disorders X-linked adrenoleukodystrophy and Zellweger syndrome in Chinese pediatric patients.
    Zhu Z; Genchev GZ; Wang Y; Ji W; Zhang X; Lu H; Sriswasdi S; Tian G
    Orphanet J Rare Dis; 2023 May; 18(1):102. PubMed ID: 37189159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.